Clinical Trials Directory

Trials / Completed

CompletedNCT04291391

The Alberta NutrIMM Study - Nutrition and Immunity

The Alberta NutrIMM (Nutrition and Immune Function) Study: Establishing the Importance of Diet and Insulin Resistance in Modulating Immune Function in Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
114 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study will investigate the effect of body weight, diet, and high blood sugar levels, under controlled feeding conditions, on immune function in individuals with and without obesity. This study will be a non-randomized, four-arm parallel group, clinical trial under controlled feeding conditions (4-week nutritional intervention using a North American-type diet). A sample size of n=128 participants will be allocated into one of the following groups: * Individuals without obesity and normoglycemia (NG) (Lean-NG) * Individuals with obesity and normoglycemia (Obese-NG) * Individuals with obesity and glucose intolerance (GI) (Obese-GI) * Individuals with obesity and type 2 diabetes (T2D) (Obese-T2D) The following outcomes will be analyzed: * Immune cell function (ex-vivo cytokine production after stimulation with mitogen and T cell proliferation); * Immune cell phenotypes; * Systemic inflammation (C-reactive protein and plasma cytokines); * Glucose, insulin, glycated hemoglobin (HbA1c), and lipids; * Fatty acids and phospholipds composition in plasma and red blood cells membrane.

Conditions

Interventions

TypeNameDescription
OTHERNorth American-type dietAll groups will receive an isocaloric diet for 4 weeks composed of 48% of energy as carbohydrate, 17% as protein, and 35% as lipid (12.5% of saturated fat, 13% of monounsaturated fat, and 6% of polyunsaturated fat), designed to reflect as closely as possible current macronutrient intake averages in North America/Canada.America/Canada (35% of energy as fat, 12.5% as saturated fat, 13% as monounsaturated fat, 6% as polyunsaturated fat, 48% as carbohydrate, 17% as protein)

Timeline

Start date
2019-09-01
Primary completion
2023-05-16
Completion
2023-12-01
First posted
2020-03-02
Last updated
2024-02-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04291391. Inclusion in this directory is not an endorsement.

The Alberta NutrIMM Study - Nutrition and Immunity (NCT04291391) · Clinical Trials Directory